Immune dysregulation in severe influenza.
Among previously healthy children with severe influenza, the mechanisms leading to increased pathology are not understood. We hypothesized that children with severe influenza would have high levels of circulating cytokines. To examine this, we recruited patients with severe influenza and examined plasma cytokine levels as well as the ability of peripheral blood cells to respond to stimuli. Ten patients with severe influenza were enrolled during the 2005-2007 influenza seasons. We evaluated plasma cytokine levels, circulating NK cells, and responses to TLR ligands during the illness. We compared these patients with five patients with moderate influenza, six patients with respiratory syncytial virus (RSV), and 24 noninfected controls. Patients with influenza showed depressed responses to TLR ligands when compared with RSV patients and healthy controls (P<0.05). These normalized when retested during a convalescent phase. Plasma levels of IL-6, IL-12, and IFN- were elevated in influenza patients compared with controls (P<0.05). A compromised ability to produce TNF- was reproduced by in vitro infection, and the magnitude of the effect correlated with the multiplicity of infection and induction of IFN regulatory factor 4 expression. Aberrant, systemic, innate responses to TLR ligands during influenza infection may be a consequence of specific viral attributes such as a high inoculum or rapid replication and may underlie the known susceptibility of influenza-infected patients to secondary bacterial infections.
Heltzer
Meredith L
ML
Divisions of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Coffin
Susan E
SE
Maurer
Kelly
K
Bagashev
Asen
A
Zhang
Zhe
Z
Orange
Jordan S
JS
Sullivan
Kathleen E
KE
D015153:Blotting, Western; D002675:Child, Preschool; D016207:Cytokines / Q000097:blood; D005260:Female; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D006801:Humans; D007154:Immune System Diseases / Q000150:complications / Q000276:immunology* / Q000503:physiopathology*; D007223:Infant; D007251:Influenza, Human / Q000150:complications / Q000235:genetics / Q000276:immunology* / Q000503:physiopathology*; D050835:Interferon Regulatory Factors / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology / Q000821:virology; D007963:Leukocytes, Mononuclear / Q000821:virology; D008297:Male; D055627:Natural Cytotoxicity Triggering Receptor 1 / Q000276:immunology; D051193:Toll-Like Receptors / Q000378:metabolism; D000099218:Interferon Regulatory Factor-4
D016207:Cytokines; D050835:Interferon Regulatory Factors; D055627:Natural Cytotoxicity Triggering Receptor 1; D051193:Toll-Like Receptors; D000099218:Interferon Regulatory Factor-4; C112260:NCR1 protein, human